Study of Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia
Clinical trial NCT00306202 · COMPLETED
Trial details
- NCT number
- NCT00306202
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-31
- Primary completion
- 2011-05-31
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.